MAPT and Alzheimer disease: As increased tau‐related uptake in the temporal lobe on PET is considered to be an important AD signature [23, 24], our findings imply dual‐phase PiB imaging could potentially be used to assess concomitant AD in patients with CAA; this strategy may help to identify patients with CAA at high risk of neurodegeneration.